A randomised placebo-controlled trial of budesonide and prednisolone in rheumatoid arthritis.

被引：0
|
作者：
Kirwan, JR
Hallgren, R
Mielants, H
Wollheim, F
机构：
[1] Univ Bristol, Bristol, Avon, England
[2] Akad Sjukhuset, Uppsala, Sweden
[3] Univ Hosp Gent, Ghent, Belgium
[4] Univ Lund Hosp, S-22185 Lund, Sweden
来源：
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
210
引用
收藏
页码：S123 / S123
页数：1
相关论文
共 50 条
  • [21] Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis - Results from a randomized placebo-controlled trial
    Haugeberg, G
    Strand, A
    Kvien, TK
    Kirwan, JR
    ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (11) : 1293 - 1297
  • [22] Ileum-targeted steroid therapy in rheumatoid arthritis: double-blind, placebo-controlled trial of controlled-release budesonide
    P. Sheldon
    Rheumatology International, 2003, 23 : 154 - 158
  • [23] A randomised trial of differentiated prednisolone treatment in active rheumatoid arthritis. Clinical benefits and skeletal side effects
    Hansen, M
    Podenphant, J
    Florescu, A
    Stoltenberg, M
    Borch, A
    Kluger, E
    Sorensen, SF
    Hansen, TM
    ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 (11) : 713 - 718
  • [24] Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial
    Boers, Maarten
    Hartman, Linda
    Opris-Belinski, Daniela
    Bos, Reinhard
    Kok, Marc R.
    Da Silva, Jose A. P.
    Griep, Eduard N.
    Klaasen, Ruth
    Allaart, Cornelia F.
    Baudoin, Paul
    Raterman, Hennie G.
    Szekanecz, Zoltan
    Buttgereit, Frank
    Masaryk, Pavol
    Klausch, L. Thomas
    Paolino, Sabrina
    Schilder, Annemarie M.
    Lems, Willem F.
    Cutolo, Maurizio
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (07) : 925 - 936
  • [25] CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial
    van Kuijk, Arno W. R.
    Vergunst, Clarissa E.
    Gerlag, Danielle M.
    Bresnihan, Barry
    Gomez-Reino, Juan J.
    Rouzier, Regine
    Verschueren, Patrick C.
    van de Leij, Christiaan
    Maas, Mario
    Kraan, Maarten C.
    Tak, Paul P.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (11) : 2013 - 2016
  • [26] Corticosteroid-responsive pharmacodynamic transcriptional markers: Results from a randomised placebo-controlled study of rheumatoid arthritis patients treated with prednisolone
    Dickson, Marion C.
    Ellis, Joanne
    Cai, Gengqian
    Wilson, Anthony G.
    Bridges, S. Louis, Jr.
    Furst, Daniel E.
    O'Dell, James R.
    El-Gabalawy, Hani S.
    Tiffany, Courtney
    Sidiqq, Shabanna
    Bal, Joanne
    Uings, Iain J.
    Binks, Michael H.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S774 - S774
  • [27] PLACEBO-CONTROLLED TRIAL OF PREDNISOLONE IN CHILDREN INTUBATED FOR CROUP
    TIBBALLS, J
    SHANN, FA
    LANDAU, LI
    LANCET, 1992, 340 (8822): : 745 - 748
  • [28] Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis
    tenWolde, S
    Breedveld, FC
    Hermans, J
    Vandenbroucke, JP
    vandeLaar, MAFJ
    Markusse, HM
    Janssen, M
    vandenBrink, HR
    Dijkmans, BAC
    LANCET, 1996, 347 (8998): : 347 - 352
  • [29] A randomised placebo controlled trial of low dose oral prednisolone in the treatment of early, active rheumatoid arthritis - The effect on clinical disease activity
    McCarey, D
    Capell, HA
    Porter, DR
    Thomson, EA
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S369 - S369
  • [30] SULFASALAZINE IN RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    PINALS, RS
    KAPLAN, SB
    LAWSON, JG
    HEPBURN, B
    ARTHRITIS AND RHEUMATISM, 1986, 29 (12): : 1427 - 1434
12345